Aramore: The Biotech Skincare Brand Honored in BeautyMatter NEXT50
A cutting-edge skincare brand, Aramore, has just been honored with one of the beauty industry’s most prestigious accolades. Based in Beverly, Massachusetts, Aramore was named a 2026 BeautyMatter NEXT50 brand on July 1, 2026. This annual distinction celebrates the most innovative and trailblazing independent companies that are shaping the future of beauty and wellness.
Aramore’s standout technology is centered on topical NAD+ science, a revolutionary approach to skin longevity. NAD+ (nicotinamide adenine dinucleotide) is a molecule found in all living cells. It powers energy production and cellular renewal, but it naturally declines starting in our 20s, contributing to visible signs of aging. Aramore’s proprietary NAD+ Precursor Complex is engineered to penetrate the basal layer of the skin and replenish NAD+ at the source, restoring the skin’s capacity to renew, regenerate, and re-energize.
Backed by research from Harvard and MIT scientists, Aramore is described as the first clinically-proven NAD+ boosting treatment to address skin aging at the cellular level. Co-founder and Harvard skin biologist Dr. Anna Mandinova discovered that combining nicotinamide mononucleotide (NMN) with ketones and fatty acids can boost NAD+ in skin cells — a breakthrough in topical skincare.
“This recognition from BeautyMatter is an exciting milestone for Aramore,” said CEO Melisse Shaban. “Our mission has been to provide consumers with a different approach to skincare at a cellular level.”
The BeautyMatter NEXT50 list highlights independent brands with the promise to reshape the future of beauty through innovation, creativity, and purpose.
Source: PR Newswire – Aramore Selected as a 2026 BeautyMatter NEXT50